Showing results (51-60 of 366) with videos related to
Sort By:
Pageof 37
Breast Cancer Research and Treatment|November 9, 2007
Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 studySofyan M Radaideh, George W SledgeNature Clinical Practice. Oncology|March 1, 2007
Drug insight: VEGF as a therapeutic target for breast cancerBryan P Schneider, George W SledgeJAMA Network Open|February 28, 2022
Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast CancerShoshana M Rosenberg, Anne O'Neill, Karen Sepucha, et al.Journal of Molecular Medicine (Berlin, Germany)|January 9, 2015
The future of breast cancer systemic therapy: the next 10 yearsMelinda L Telli, George W SledgeBreast Cancer Research : BCR|June 13, 2009
Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?Bryan P Schneider, George W SledgeSeminars in Oncology|June 27, 2006
Protein kinase C-beta as a therapeutic target in breast cancerGeorge W Sledge, Yesim Gökmen-PolarBreast Cancer Research and Treatment|October 14, 2006
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissueLida Mina, Sharon E Soule, Sunil Badve, et al.Breast Cancer Research and Treatment|March 4, 2014
Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103Kathryn J Ruddy, Anne O'Neill, Kathy D Miller, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
The oncologist as the patient with cancer or relativeTeresa Gilewski, Martin Raber, George W SledgeJAMA Oncology|June 27, 2015
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast CancerAnn H Partridge, Karen Sepucha, Anne O'Neill, et al.Pageof 37